Browse by author
Lookup NU author(s): Professor Gerard Stansby
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Thromboelastography (TEG) is a useful measure of coagulation. Modified TEG (that is with the addition of a GP IIb/IIIa receptor antagonist) has been used to assess the contribution of the fibrinogen-platelet interaction to TEG parameters (in particular the maximum amplitude, MA). Modified TEG was compared with other investigations of platelet function to assess its sensitivity in both normal subjects and in patients with peripheral arterial disease (PAD), a condition associated with activated platelets. Blood was collected from eight healthy subjects and 12 PAD patients. Platelet function was measured by TEG, flow cytometry (using PAC-1, P-selectin, GP Ilia and GP Ib murine antibodies) and platelet aggregometry (spontaneous and ADP-induced) in the presence and absence of tirofiban (a GP IIb/IIIa receptor antagonist). TEG showed a statistically significant reduction in MA with tirofiban at 0.4 mg/L and an increase in k (kinetic time; which indicates how fast clot strength is increasing once clotting starts) at 0.2 and 0.4 mg/L of tirofiban in both healthy subjects and PAD patients. Flow cytometry showed a significant decrease in the PAC-1 binding index (at 0.2 mg/L). This finding was compatible with the significant reductions found in spontaneous and ADP-induced platelet aggregation. However, aggregometry and flow cytometry were more sensitive indicators of platelet inhibition than the TEG parameters. TEG does not provide a comprehensive or sensitive reflection of impaired platelet function. If TEG is used as an index of severely impaired platelet function, we recommend that the k parameter should be used as well as MA. TEG should be supplemented by other methods of platelet function assessment wherever possible.
Author(s): Bowbrick VA, Mikhailidis DP, Stansby G
Publication type: Article
Publication status: Published
Journal: Clinical and Applied Thrombosis/Hemostasis
Year: 2003
Volume: 9
Issue: 2
Pages: 137-142
Print publication date: 01/04/2003
ISSN (print): 1076-0296
ISSN (electronic): 1938-2723
Publisher: Sage Publications
URL: http://dx.doi.org/10.1177/107602960300900208
DOI: 10.1177/107602960300900208
PubMed id: 12812383
Altmetrics provided by Altmetric
